Trifluoperazine hydrochloride and Portal hypertension - a phase IV clinical study of FDA data

Summary:

Portal hypertension is reported only by a few people who take Trifluoperazine Hydrochloride.

The phase IV clinical study analyzes which people take Trifluoperazine hydrochloride and have Portal hypertension. It is created by eHealthMe based on reports of 154 people who have side effects while taking Trifluoperazine hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

154 people reported to have side effects when taking Trifluoperazine hydrochloride.
Among them, 3 people (1.95%) have Portal hypertension.

What is Trifluoperazine hydrochloride?

Trifluoperazine hydrochloride has active ingredients of trifluoperazine hydrochloride. eHealthMe is studying from 169 Trifluoperazine hydrochloride users for its effectiveness, alternative drugs and more.

What is Portal hypertension?

Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system) is found to be associated with 1,034 drugs and 562 conditions by eHealthMe.

Number of Trifluoperazine hydrochloride and Portal hypertension reports submitted per year:

Could Trifluoperazine hydrochloride cause Portal hypertension?

Gender of people who have Portal hypertension when taking Trifluoperazine hydrochloride *:

female: 0.0 %
male: 100 %

Age of people who have Portal hypertension when taking Trifluoperazine hydrochloride *:

Common drugs people take besides Trifluoperazine hydrochloride *:

Rezulin: 3 people, 100.00%
Hydrochlorothiazide: 2 people, 66.67%
Etodolac: 2 people, 66.67%
Lodine: 1 person, 33.33%

Common side effects people have besides Portal hypertension *:

Fatty Liver: 3 people, 100.00%
Hepatic Failure (liver failure): 3 people, 100.00%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 100.00%
Blood Carbon Dioxide Decreased: 3 people, 100.00%
Cellulitis (infection under the skin): 3 people, 100.00%
Electrolyte Imbalance: 3 people, 100.00%
Activated Partial Thromboplastin Time Prolonged: 3 people, 100.00%
Pneumonia Klebsiella (pneumonia caused by bacteria klebsiella): 3 people, 100.00%
Septicaemia Streptococcal (blood infection with bacteria): 3 people, 100.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Trifluoperazine hydrochloride and have Portal hypertension?

Check whether Portal hypertension is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

COVID vaccines that are related to Portal hypertension:

Common drugs associated with Portal hypertension:

All the drugs that are associated with Portal hypertension:

Portal hypertension (1,034 drugs)

Common conditions associated with Portal hypertension:

Hiv infection: 352 reports
Hepatitis c: 147 reports
Colon cancer: 144 reports

All the conditions that are associated with Portal hypertension:

Portal hypertension (562 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trifluoperazine hydrochloride (the active ingredients of Trifluoperazine hydrochloride) and Trifluoperazine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.